Περισκόπιο Covid-19


Παράθεση πηγών, από το διαδίκτυο, για το φαινόμενο " Covid-19"!

(Συγκέντρωση στοιχείων μέχρι 15Οκτ2021)

.
  • Κοινοποίησε σε:

 

 

https://childrenshealthdefense.org/defender/cdc-panel-support-booster-shots-vaers-reports-injuries-deaths-covid-vaccines/

https://childrenshealthdefense.org/defender/mathematically-impossible-vaccines-eliminate-covid/

https://rumble.com/vkbeyd-140-hospitalized-people-out-of-141-cases-in-sydney-had-both-covid-jabs-othe.html

https://www.maariv.co.il/corona/corona-israel/Article-855728

https://childrenshealthdefense.org/defender/scientist-warning-covid-vaccines-parkinson-neurodegenerative-disorders/

https://www.israelnationalnews.com/News/News.aspx/308653

https://www.israelnationalnews.com/News/News.aspx/309762

https://www.israelnationalnews.com/News/News.aspx/310845

https://in.news.yahoo.com/vaccinated-people-singapore-three-quarters-071043455.html

https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00367-0/fulltext

https://www.medpagetoday.com/infectiousdisease/covid19vaccine/93830

https://www.bloomberg.com/news/articles/2021-07-30/cdc-scaled-back-hunt-for-breakthrough-cases-just-as-the-delta-variant-grew

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01642-1/fulltext

https://sacramento.cbslocal.com/2021/07/26/covid-vaccination-california-counties/

https://freewestmedia.com/2021/07/28/iceland-vaccines-do-not-work/

https://www.cnbc.com/2021/08/13/27-vaccinated-people-test-positive-for-covid-on-a-carnival-cruise-ship.html

https://www.newsweek.com/7-vaccinated-florida-patients-die-covid-nurse-calls-situation-disturbing-1620118

Εξαιρετικά σημαντικό.

Μπορούμε όλοι να κάνουμε κάτι για να φανερωθεί και να διαδοθεί παντού η αλήθεια για τα εμβόλια.

Όποιος έχει γνωστούς που εμβολιάστηκαν, μπορεί να τους προτείνει να κάνουν την εξέταση D-dimers, καθώς και επίχρισμα περιφερικού αίματος, δηλαδή εξέταση του αίματος και των ερυθρών αιμοσφαιρίων σε μικροσκόπιο.

Με τις εξετάσεις αυτές θα φανεί πως στο αίμα πολλών εμβολιασμένων υπάρχουν πολλές ανωμαλίες των ερυθρών αιμοσφαιρίων και πολλά μικρά συσσωματώματα τα οποία προκαλούν τις μεγάλες, αλλά και τις μικρές θρομβώσεις, οι οποίες σε βάθος χρόνου μπορούν να καταστρέψουν τα όργανά τους.

Με τον τρόπο αυτό βοηθάμε τους εμβολιασμένους που έχουν την ψευδαίσθηση πως είναι υγιείς, επειδή δεν έχουν άμεσες παρενέργειες, να συνειδητοποιήσουν το πρόβλημα στο αίμα τους και να πάρουν θεραπευτική αγωγή, ώστε να γλιτώσουν τα χειρότερα σε βάθος χρόνου. Ταυτόχρονα, θα φανερωθεί και θα διαδοθεί μαζικά, από στόμα σε στόμα, η αλήθεια για τα εμβόλια.

Στο παρακάτω βίντεο ο διακεκριμένος παγκοσμίου φήμης γιατρός Sucharit Bhakdi προτείνει την εξέταση D dimers για όσους έχουν εμβολιαστεί. Λέει πως αν τα αποτελέσματα της εξέτασης είναι υψηλά, αυτό είναι απόδειξη πως έχουν σχηματιστεί μικροί θρόμβοι στα αγγεία. Επίσης, λέει πως ομάδα Γερμανών γιατρών έκανε την εξέταση αυτή σε άτομα πριν και μετά τον εμβολιασμό τους και διαπίστωσε πως μετά τον εμβολιασμό, αυξήθηκαν οι τιμές της D dimers.

 https://rumble.com/viu5n9-31640085.html

Βίντεο με μαρτυρίες γερμανών γιατρών και αποδείξεις με φωτογραφίες μικροσκοπίου για τις ανωμαλίες των ερυθρών αιμοσφαιρίων στο αίμα των εμβολιασμένων.

https://rumble.com/vlhlzt-36093593.html

Ο γιατρός Dr Philippe van Welbergen διαπίστωσε περίεργες ανωμαλίες στα ερυθρά αιμοσφαίρια στο αίμα των εμβολιασμένων. Αποδείξεις με φωτογραφίες μικροσκοπίου.

https://www.heartpublications.co.uk/unusual-formations-in-vaccinated-blood/

Βίντεο με τον καναδό γιατρό Dr. Charles Hoffe ο οποίος μιλάει και αυτός για τις μικροσκοπικές θρομβώσεις που προκαλούν τα εμβόλια covid 19.

https://newtube.app/fake_pandemic/6AE70ZF?__cf_chl_jschl_tk__=pmd_YsQFvrOeDzV2JJaVPSkVJh.sAbPiz_LivXQwcykfvqI-1630157954-0-gqNtZGzNAiWjcnBszQkl

Λοιπόν, ξανακάνω μια σούμα για τον ΑΝΥΠΑΡΚΤΟ ΙΟ!!!! Και έχετέ το εύκαιρο να το δείξετε σε όποιον ισχυριζεται το αντίθετο!!!

Ο ΦΑΝΤΟΜΑΣ ΙΟΣ!!!!Ο ΕΠΙΚΗΡΥΓΜΕΝΟΣ ΓΙΑ € 270.0000!!!!

https://ellinikiafipnisis.blogspot.com/2021/02/o-fantomas-ios-se-anazitisi-tou-sars-cov-2.html?m=1

Ιρλανδική κυβέρνηση

https://principia-scientific.com/irish-government-admits-covid-19-does-not-exist/

CDC, Καναδάς και άλλα 46 ιδρυματα.

http://greeknewsondemand.com/2021/02/01/%CE%AD%CF%81%CE%B5%CF%85%CE%BD%CE%B1-%CF%83%CE%BF%CE%BA-%CE%BA%CE%B1%CE%BD%CE%B1%CE%B4%CE%AD%CE%B6%CF%89%CE%BD-%CE%B5%CF%81%CE%B5%CF%85%CE%BD%CE%B7%CF%84%CF%8E%CE%BD-%CE%B4%CE%B5%CE%BD-%CE%B1%CF%80/

Dr. Kaufman Dr. Cowan

https://scripta---manent.blogspot.com/2021/03/dr-andrew-kaufman-dr-tom-cowan-sally.html?m=1

ΟΙ ΑΝΥΠΑΡΚΤΕΣ ΜΕΤΑΛΛΑΞΕΙΣ ΤΟΥ ΑΝΥΠΑΡΚΤΟΥ ΙΟΥ.

ΟΙ ΜΟΝΟΙ ΠΟΥ ΘΑ ΜΕΤΑΛΛΑΧΤΟΥΝ ΕΙΝΑΙ ΟΣΟΙ ΕΚΑΝΑΝ ΤΑ ‘’ΕΜΒΟΛΙΑ’’… ΣΕ ΖΟΜΠΙ ΜΑΣ ΕΙΠΕ Ο FAUCI. ΕΣΕΙΣ ΒΑΛΤΕ ΔΑΙΜΟΝΕΣ ΓΙΑ ΝΑ ΕΙΣΤΕ ΜΕΣΑ!!!!

https://ellinikiafipnisis.blogspot.com/2021/03/i-proeidopoihsi-tou-cdc-gia-mia-apokalipsi-zombie-ta-emvolia-kata-tou-covid-kai-o-kindinos-nosou-prion.html?m=1

ΑΧ μόνο να ξερανε τι ΠΑΤΕΝΤΑΡΙΣΜΕΝΗ τεχνολογία έχουνε μέσα αυτές οι ΕΝΕΣΕΙΣ ΓΟΝΙΔΙΑΚΗΣ ΜΕΤΑΛΛΑΞΗΣ!!!!!!Για να μη μιλήσω για παράσιτα και smart dust και νανοσωματίδια και τοξικά χημικά σε τεστ και μάσκες. Σας τα έχω στείλει…

https://ellinikiafipnisis.blogspot.com/2021/03/Oi-metallaxeis-tou-sarscov2-oi-akides-proteinis-kai-ola-ta-ypoloipa-stirizontai-se-mia-terastia-paxia-ypothesi-pou-den-apodeiknyetai.html?m=1

Ανύπαρκτος ιός και μηνύσεις πανεπιστημιων στο CDC ΓΙΑ ΤΗΝ ΑΠΑΤΗ COVID-19! https://rumble.com/vfnc07-.-covid-.-a-b..html

ΧΩΡΙΑ ΠΟΥ ΟΣΟΙ ΦΕΡΟΥΝ ΜΕΣΑ ΤΟΥΣ ΠΑΤΕΝΤΑΡΙΣΜΕΝΗ ΤΕΧΝΟΛΟΓΙΑ, ΘΕΩΡΟΥΝΤΑΙ TRANSHUMAN ΚΑΙ ΕΙΝΑΙ ΙΔΙΟΚΤΗΣΙΑ ΤΩΝ ΠΑΝΤΕΝΤΟΥΧΩΝ!!!

https://kanenazori.com/2021/07/31/apisteyti_apofasi_anthrwpoi_idioktisia/

ΗΠΑ: Εργαστήρια Αδυνατούν να Βρουν Covid-19 σε 1.500 Θετικά Τεστ – Επιβράβευση 1.500.000 € για Όποιον Αποδείξει Επιστημονικά Ότι ο SARS-CoV-2 Υφίσταται!

https://tgnews.gr/%CE%B7%CF%80%CE%B1-%CE%B5%CF%81%CE%B3%CE%B1%CF%83%CF%84%CE%AE%CF%81%CE%B9%CE%B1-%CE%B1%CE%B4%CF%85%CE%BD%CE%B1%CF%84%CE%BF%CF%8D%CE%BD-%CE%BD%CE%B1-%CE%B2%CF%81%CE%BF%CF%85%CE%BD-covid-19-%CF%83/

«Αυτά βρήκαμε στο αίμα εμβολιασμένων»: Επιστήμονες στην Γερμανία προκαλούν «ΣΕΙΣΜΟ»

https://www.triklopodia.gr/%ce%b1%cf%85%cf%84%ce%ac-%ce%b2%cf%81%ce%ae%ce%ba%ce%b1%ce%bc%ce%b5-%cf%83%cf%84%ce%bf-%ce%b1%ce%af%ce%bc%ce%b1-%ce%b5%ce%bc%ce%b2%ce%bf%ce%bb%ce%b9%ce%b1%cf%83%ce%bc%ce%ad%ce%bd%cf%89%ce%bd/

https://www.el.gr/ygeia/health-news/ayta-vrikame-sto-aima-emvoliasmenon/

Please watch and comment

Psychological basis for crimes against humanity by average people

-1951. Asch experiment on conformity

https://youtu.be/TYIh4MkcfJA

-1963. Milgrim experiment on obedience

https://youtu.be/FEaKl5_Nn3w

-1972. Stanford prison guard experiment

https://youtu.be/KND_bBDE8RQ

Support and evidence of population control agenda

-2001. Operation Dark Winter

https://en.m.wikipedia.org/wiki/Operation_Dark_Winter

-2010. Rockefeller’s “Lockstep Scenario”. From the their official website.

www.rockefellerfoundation.org/blog/innovating-for-a-bold-future/

-2015. Gates Reduce population video

https://youtu.be/wfstBe1buaA

-2016. Kraus Shwalb within 10 years chip everyone

www.youtube.com/watch?v=UmQNA0HL1pw

-2017. Fauci predicts pandemic

https://news.yahoo.com/2017-dr-fauci-predicted-pandemic-171500889.html

-2019. Event 201 drill for the pandemic

www.centerforhealthsecurity.org/event201/about

-2019. John Hopkins emergency preparedness for upcoming pandemic

https://apps.who.int/gpmb/assets/thematic_papers/tr-6.pdf

-2020. Gates states 7 billion people will need the vaccine

https://finance.yahoo.com/news/bill-gates-says-world-7-190044086.html

-ID 2020. Note who is funding this

https://id2020.org/alliance

-2030. World Economic Forum vision for you

https://www.youtube.com/watch?v=lBBxWtKKQiA

Population control advocates

1920. Margaret Sanger inspires Hitler and forms planned parenthood

https://www.americamagazine.org/politics-society/2020/07/28/margaret-sangers-extreme-brand-eugenics

1970. Prince Philip

https://www.leakedreality.com/video/6618/prince-philip-the-long-planned-depopulation-control-is-here-covid-19-the-plandemic?comment_to_load=186513

1977. Dr John Holdren

https://www.youtube.com/watch?v=ttvCwQuFhk8

-2000. Dr Eric Pianka

https://youtu.be/462Fc-sRcDo

-2013. Ted Turner

https://youtu.be/oZzpZVUfWBc

-2017. Black Genocide in 21st Century

https://www.youtube.com/watch?v=I6XfU8KVkzI

-2020. Eugenic sterilization laws in the United States

https://www.hli.org/resources/eugenic-sterilization/

Prehospital treatment Covid-19

-2003. Lancet paper on how chloroquine works

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128816/

-2005. Virology proving that chloroquine/ Hcq works against SARS

https://pubmed.ncbi.nlm.nih.gov/16115318/

-2020. Peer reviewed paper demonstrating reduction in hospitalization and death by 84% from covid-19 with the zelenko protocol

https://www.sciencedirect.com/science/article/pii/S0924857920304258

2020. Thorough review of covid-19 treatment

https://rcm.imrpress.com/EN/10.31083/j.rcm.2020.04.264

https://www.amjmed.com/action/showPdf?pii=S0002-9343%2820%2930673-2

https://hcqmeta.com/

https://ivmmeta.com/

https://vdmeta.com/

https://pubs.acs.org/doi/10.1021/jf5014633

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318306/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365891/

2021. https://m.theepochtimes.com/weight-adjusted-hydroxychloroquine-and-azithromycin-boosted-survival-of-ventilated-covid-19-patients-by-200-percent-study_3851028.html/amp

For those who tell you that the Covid-19 injection is authorised, approved or licensed remind them of these facts, especially if they are considering that the C19 injection is a good idea for children:

The injections are still in Stage 3 Clinical Trials that do not finish until early 2023:

Currently given emergency approval (EUA), Conditional Marketing Authorisation (CMA) etc all these terms mean they are only being used because of an “emergency” situation. These injections have not been fully licensed anywhere in the world.

AstraZeneca Trials: AZ Trials

Pfizer Trials :Pfizer Trials

AZ example short term approval terms: AZ Approval Terms

Pfizer example short term approval terms : Pfizer Approval Terms

The public should only begin to use drugs or vaccines that are in Stage 4 clinical trials

Pfizer tells us this : Stage 3 not normal

The animals trials for coronavirus vaccines have always failed because the animals got sick and/or died :

Studies in Ferrets : https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035421

Cats: https://www.jstage.jst.go.jp/article/jvms/60/1/60_1_49/_article

Mice : https://pubmed.ncbi.nlm.nih.gov/22536382/

Mice: https://pubmed.ncbi.nlm.nih.gov/17194199/

Mice: https://pubmed.ncbi.nlm.nih.gov/18941225/

The initial trials were short and flawed:

More information on the vaccines is shown in the links below:

Pfizer Trials

AZ Trials

Covid-19 Injection information leaflet

What is the latest scientific evidence saying on the efficacy/ effectiveness of these Vaccines:

Absolute Risk Reduction i.e. the true impact that the injection itself was shown to have at reducing your chances of getting sick with Covid-19 was just 0.84% for Pfizer and 1.28% for AZ (per the Lancet study linked below).

Link https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00069-0/fulltext

The injections have numerous serious and fatal short term side effects and no long term safety data

Link Adverse Reaction :https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions

If the injections don’t work on “the variants” (given people are still getting sick and dying and indeed in increasing numbers) , why continue to inject people with these same experimental injections that has shown themselves not to work?

Μετάφραση:

(Για όσους σας λένε ότι η ένεση Covid-19 είναι εγκεκριμένη, εγκεκριμένη ή αδειοδοτημένη, θυμηθείτε τους αυτά τα γεγονότα, ειδικά αν θεωρούν ότι η ένεση C19 είναι μια καλή ιδέα για παιδιά:

 Οι ενέσεις βρίσκονται ακόμα σε κλινικές δοκιμές σταδίου 3 που δεν ολοκληρώνονται μέχρι τις αρχές του 2023:

 Επί του παρόντος έχει λάβει έγκριση έκτακτης ανάγκης (EUA), Condition Marketing Authorization (CMA) κλπ. Όλοι αυτοί οι όροι σημαίνουν ότι χρησιμοποιούνται μόνο λόγω μιας κατάστασης «έκτακτης ανάγκης». Αυτές οι ενέσεις δεν έχουν λάβει πλήρη άδεια οπουδήποτε στον κόσμο.

 Δοκιμές AstraZeneca: Δοκιμές AZ

 Δοκιμές Pfizer: Δοκιμές Pfizer

 Παράδειγμα όρων βραχυπρόθεσμης έγκρισης AZ: Όροι έγκρισης AZ

 Παράδειγμα όρων βραχυπρόθεσμης έγκρισης Pfizer: Όροι έγκρισης Pfizer

 Το κοινό θα πρέπει να αρχίσει να χρησιμοποιεί φάρμακα ή εμβόλια που βρίσκονται σε κλινικές δοκιμές σταδίου 4

 Η Pfizer μας λέει αυτό: Το στάδιο 3 δεν είναι φυσιολογικό

 Οι δοκιμές σε ζώα για εμβόλια κατά του κορωνοϊού πάντα απέτυχαν επειδή τα ζώα αρρώστησαν ή/και πέθαναν:

 Μελέτες σε κουνάβια: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035421

 Γάτες: https://www.jstage.jst.go.jp/article/jvms/60/1/60_1_49/_article

 Ποντίκια: https://pubmed.ncbi.nlm.nih.gov/22536382/

 Ποντίκια: https://pubmed.ncbi.nlm.nih.gov/17194199/

 Ποντίκια: https://pubmed.ncbi.nlm.nih.gov/18941225/

 Οι αρχικές δοκιμές ήταν σύντομες και ελαττωματικές:

 Περισσότερες πληροφορίες για τα εμβόλια εμφανίζονται στους παρακάτω συνδέσμους:

 Δοκιμές Pfizer

 Δοκιμές AZ

 Φυλλάδιο πληροφοριών για την ένεση Covid-19

 Ποια είναι τα τελευταία επιστημονικά στοιχεία που λένε για την αποτελεσματικότητα/ αποτελεσματικότητα αυτών των εμβολίων:

 Η Απόλυτη Μείωση Κινδύνου, δηλαδή ο πραγματικός αντίκτυπος που αποδείχθηκε ότι είχε η ίδια η ένεση στη μείωση των πιθανοτήτων να αρρωστήσετε με Covid-19 ήταν μόλις 0,84% για την Pfizer και 1,28% για την AZ (σύμφωνα με τη μελέτη Lancet που συνδέεται παρακάτω).

 Σύνδεσμος https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00069-0/fulltext

 Οι ενέσεις έχουν πολυάριθμες σοβαρές και θανατηφόρες βραχυπρόθεσμες παρενέργειες και χωρίς μακροπρόθεσμα δεδομένα ασφάλειας

 Σύνδεσμος Ανεπιθύμητη αντίδραση: https: //www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions

 Εάν οι ενέσεις δεν λειτουργούν στις «παραλλαγές» (δεδομένου ότι οι άνθρωποι εξακολουθούν να αρρωσταίνουν και πεθαίνουν και μάλιστα σε αυξανόμενο αριθμό), γιατί να συνεχίσουμε να εγχύουμε στους ανθρώπους αυτές τις ίδιες πειραματικές ενέσεις που έχουν αποδειχθεί ότι δεν λειτουργούν;

ΔΕΙΤΕ ΛΙΓΟ ΑΥΤΟ..

ΥΠΕΡΟΧΗ ΕΡΓΑΣΙΑ ΣΠΙΤΙΟΥ !!!!!!

 «Συγκέντρωσα όλα τα συστατικά του εμβολίου σε μια λίστα και επικοινώνησα με το Poison Control.

 Εγώ: Μια βιομηχανία … αυτά είναι τα συστατικά που χρησιμοποιούνται στα εμβόλια … Με συνδετικούς παράγοντες για διασφαλίσουν ότι το σώμα δεν θα τα ξεπλύνει … Για να διατηρήσετε τα επίπεδα των αντισωμάτων επ ‘αόριστον …

 Κάτωθι είναι ΜΟΝΟ μερικά από τα συστατικά εμβολίου.

 Αυτά εισέρχονται στα παιδιά σας και σε εσάς!

 Formaldehyde/Formalin –

- Πολύ τοξικό συστηματικό δηλητήριο και καρκινογόνο.

Betapropiolactone – Τοξικό χημικό και καρκινογόνο. Μπορεί να προκαλέσει θάνατο/μόνιμο τραυματισμό μετά από πολύ σύντομη έκθεση σε μικρές ποσότητες. Διαβρωτική χημική ουσία.

 Hexadecyltrimethylammonium bromide –

 Μπορεί να προκαλέσει βλάβη στο συκώτι, το καρδιαγγειακό σύστημα και το κεντρικό νευρικό σύστημα. Μπορεί να προκαλέσει αναπαραγωγικά αποτελέσματα και γενετικές ανωμαλίες.

 Aluminum hydroxide, aluminum phosphate, and aluminum salts – Neurotoxin.

 Αργιλίου, φωσφορικό αργίλιο και άλατα αργιλίου – Νευροτοξίνη. Κινδυνεύει για μακροχρόνια φλεγμονή/διόγκωση του εγκεφάλου, νευρολογικές διαταραχές, αυτοάνοσες ασθένειες, Αλτσχάιμερ, άνοια και αυτισμό. Διεισδύει στον εγκέφαλο όπου επιμένει επ ‘αόριστον.

Thimerosal (mercury) – Neurotoxin.

 H️Θιμεροσάλη (υδράργυρος) – Νευροτοξίνη. Προκαλεί κυτταρική βλάβη, μειώνει τη δραστηριότητα μείωσης της οξείδωσης, τον κυτταρικό εκφυλισμό και τον κυτταρικό θάνατο. Συνδέεται με νευρολογικές διαταραχές, Αλτσχάιμερ, άνοια και αυτισμό.

Polysorbate 80 20 –

- Παραβιάζει το αιματοεγκεφαλικό φράγμα και φέρει μαζί του αλουμίνιο, θυμεροσάλη και ιούς. Επιτρέποντάς του να εισέλθει στον εγκέφαλο.

 Glutaraldehyde –

 Τοξική χημική ουσία που χρησιμοποιείται ως απολυμαντικό για θερμοευαίσθητο ιατρικό εξοπλισμό.

 Fetal Bovine Serum-

Εμβρυϊκός ορός βοοειδών – Συλλέγεται από έμβρυα βοοειδών (αγελάδων) που λαμβάνονται από έγκυες αγελάδες πριν από τη σφαγή.

 Human Diploid Fibroblast Cells –

Ανθρώπινα διπλοειδή ινοβλάστη κύτταρα – εμβρυϊκά κύτταρα που έχουν διακοπεί. Το ξένο DNA έχει την ικανότητα να αλληλεπιδρά με το δικό μας.

 African Green Monkey Kidney Cells –

Νεφρικά κύτταρα αφρικανικού πιθήκου-Μπορεί να μεταφέρει τον ιό που προκαλεί τον καρκίνο SV-40 και έχει ήδη μολύνει περίπου 30 εκατομμύρια Αμερικανούς.

 Acetone ασετόν

- Μπορεί να προκαλέσει βλάβη στα νεφρά, το συκώτι και τα νεύρα.

 E.Coli – Ναι, καλά διαβάσατε.

DNA from porcine (pig) Circovirus type1 –

DNA από χοίρους (χοίρους) Circovirus τύπου-1

 Human embryonic lung cell cultures

Ανθρώπινες εμβρυϊκές καλλιέργειες πνευμονικών κυττάρων (από αποβληθέντα έμβρυα)

Θα ️Μπορείτε να δείτε όλα αυτά τα συστατικά στον ιστότοπο των CDC. Προτρέπω τον καθένα να κάνει τη δική του έρευνα. Αναζητήστε το MSDS για αυτές τις χημικές ουσίες. Διαβάστε τις χιλιάδες μελέτες που έχουν αξιολογηθεί από ομοτίμους που έχουν αξιολογήσει τις βιολογικές συνέπειες που μπορούν να έχουν αυτές οι χημικές ουσίες στο σώμα, ειδικά όταν εγχέονται.

 Ακριβής έλεγχος των συστατικών του εμβολίου εδώ:

 https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/b/excipient-table-2.pdf

 ΠΑΡΑΚΑΛΩ ΜΟΙΡΑΣΤΕΙΤΕ!!!

 www.cdc.gov

 cdc.gov

Βιβλιογραφία

1. Li WH, Moore MJ, Vasilieva N, Sui JH, Wong SK, Berne MA. Et al. Angiotensin-converting enzyme is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–4.

2. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020. 01.26.919985.

3. Roca-Ho H, Riera M, Palau V, Pascual J, Soler MJ. Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse. Int J Mol Sci. 2017. 18.

4. An overview of the immune system. J Parkin 1 , B Cohen. Lancet 2001; 2;357(9270):1777-89.

5. A brief review of the immune system. R Alam . Prim Care 1998 Dec;25(4):727-38.

6. The biology of the immune system. D P Huston. JAMA 1997 Dec 10;278(22):1804-14.

7. Autoimmunity. Betty Diamond . Immunol Rev. 2005;204:5-8.

8. Vaccines and autoimmunity. Nancy Agmon-Levin 1 , Ziv Paz, Eitan Israeli, Yehuda Shoenfeld. Nat Rev Reumatol. 2009;5(11):648-52.

9. Vaccines, adjuvants and autoimmunity. Luísa Eça Guimarães, Britain Baker , Carlo Perricone, Yehuda Shoenfeld. Pharmacol Res. 2015;100:190-209.

10. The SARS-CoV-2 as an instrumental trigger of autoimmunity

Arad Dotan , Sylviane Muller, Darja Kanduc, Paula David, Gilad Halpert, Yehuda Shoenfeld. Autoimmun Rev 2021:20:102792.

11. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.

Aristo Vojdani, Datis Kharrazian Clin Immunol 2020;217:108480.

12. Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine]

Almudena Ramírez-García, Sara Lozano Jiménez, Ignacio Darnaude Ximénez, Alberto Gil Cacho, Ramón Aguado-Noya, Javier Segovia Cubero Rev Esp Cardiol 2021;12.

Doi: 10.1016/j.recesp.2021.06.006.

13. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Vojdani A, Kharrazian D. Clin Immunol. 2020;217:108480.

14. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Velikova T, Georgiev T. Rheumatol Int. 2021;41(3):509-518.

15. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention. Kasperkiewicz M. Cell Stress Chaperones. 2021;26(1):1-2.

16. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19. Cimolai N. SN Compr Clin Med. 2021;22:1-16.

17. Another case of autoimmune hepatitis after SARS-CoV-2 vaccination. Still casualty?

Londoño MC, Gratacós-Ginès J, Sáez-Peñataro J. J Hepatol. 2021;12:S0168-8278(21)00417-7. Doi: 10.1016/j.jhep.2021.06.004.

18. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine.

Dias L, Soares-Dos-Reis R, Meira J, Ferrão D, Soares PR, Pastor A, Gama G, Fonseca L, Fagundes V, Carvalho M. J Stroke Cerebrovasc Dis. 2021;30(8):105906

19. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine.

Dias L, Soares-Dos-Reis R, Meira J, Ferrão D, Soares PR, Pastor A, Gama G, Fonseca L, Fagundes V, Carvalho M. J Stroke Cerebrovasc Dis. 2021;30(8):105906.

20. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Zakaria Z, Sapiai NA, Ghani ARI. Acta Neurochir (Wien). 2021;163(8):2359-2362.

21. Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Castelli GP, Pognani C, Sozzi C, Franchini M, Vivona L. Crit Care. 2021;12;25(1):137.

22. ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST). Suresh P, Petchey W. BMJ Case Rep. 2021;16;14(6):e243931.

23. SARS-CoV-2 vaccine-induced cerebral venous thrombosis.

Ciccone A. Eur J Intern Med. 2021;89:19-21.

24. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.

Cari L, Fiore P, Naghavi Alhosseini M, Sava G, Nocentini G. J Autoimmun. 2021;122:102685.

25. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines. Hwang J, Lee SB, Lee SW, Lee MH, Koyanagi A, Jacob L, Tizaoui K, Yon DK, Shin JI, Smith L. J Autoimmun. 2021;122:102681.

26. Thrombotic Thrombocytopenia and Central Venous Sinus Thrombosis Post – COVID-19 Vaccination and its Treatment with Heparin Alternatives.

Sheikh S. J Coll Physicians Surg Pak. 2021;31(7):149.

27. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination – A report of two UK cases.

Mehta PR, Apap Mangion S, Benger M, Stanton BR, Czuprynska J, Arya R, Sztriha LK. Brain Behav Immun. 2021;95:514-517.

28. COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome.

Franchini M, Liumbruno GM, Pezzo M. Eur J Haematol. 2021;107(2):173-180.

29. Coronavirus (COVID-19) Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).

Aleem A, Nadeem AJ. 2021 Apr 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.

30. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.

Oldenburg J, Klamroth R, Langer F, Albisetti M, von Auer C, Ay C, Korte W, Scharf RE, Pötzsch B, Greinacher A. Hamostaseologie. 2021;41(3):184-189.

31. COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Scharf RE, Alberio L. Hamostaseologie. 2021;41(3):179-182.

32. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.

McGonagle D, De Marco G, Bridgewood C. J Autoimmun. 2021;121:102662.

33. Fatal cerebral venous sinus thrombosis after COVID-19 vaccination.

Jamme M, Mosnino E, Hayon J, Franchineau G. Intensive Care Med. 2021;47(7):790-791.

34. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients – United States, April 2021.

MacNeil JR, Su JR, Broder KR, Guh AY, Gargano JW, Wallace M, Hadler SC, Scobie HM, Blain AE, Moulia D, Daley MF, McNally VV, Romero JR, Talbot HK, Lee GM, Bell BP, Oliver SE. MMWR Morb Mortal Wkly Rep. 2021;70(17):651-656.

35. Vaccination against SARS-CoV-2 in patients with multiple sclerosis.

Costa Frossard-França L, García-Domínguez JM, Moreno-Torres I, Fortún J, Villar LM, Meca-Lallana V. Rev Neurol. 2021;72(7):250-260.

36. Thrombosis after covid-19 vaccination. Hunter PR. BMJ. 2021;373:n958.

37. Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection. Gobbi F, Buonfrate D, Moro L, Rodari P, Piubelli C, Caldrer S, Riccetti S, Sinigaglia A, Barzon L. Viruses. 2021;13(3):422.

38. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.

Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E, McCowan C, Agrawal U, Shah SA, Ritchie LD, Murray J, Pan J, Bradley DT, Stock SJ, Wood R, Chuter A, Beggs J, Stagg HR, Joy M, Tsang RSM, de Lusignan S, Hobbs R, Lyons RA, Torabi F, Bedston S, O’Leary M, Akbari A, McMenamin J, Robertson C, Sheikh A. Nat Med. 2021;27(7):1290-1297.

39. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.

Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, Goldblatt D, Kotoucek P, Thomas W, Lester W. N Engl J Med. 2021;384(23):2202-2211.

40. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management. Alam W. Sci Prog. 2021;104(2):368504211025927.

41. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.

Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, Brooks N, Smaja M, Mircus G, Pan K, Southern J, Swerdlow DL, Jodar L, Levy Y, Alroy-Preis S. Lancet. 2021;397(10287):1819-1829.

42. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. N Engl J Med. 2020;383(27):2603-2615.

43. Perspectives on vaccine induced thrombotic thrombocytopenia.

Dotan A, Shoenfeld Y. J Autoimmun. 2021;121:102663.

44. Vascular Endothelial Glycocalyx Damage in COVID-19

Minako Yamaoka-Tojo Department of Rehabilitation/Regenerative Medicine and Cell Design Research Facility, Kitasato University School of Allied Health Sciences, Sagamihara 252-0373, Japan

Department of Cardiovascular Medicine, Kitasato University Graduate School of Medical Sciences, Sagamihara 252-0373, Japan

Int. J. Mol. Sci. 2020, 21(24), 9712; https://doi.org/10.3390/ijms21249712

45. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity

Somasundaram Raghavan, Divya Borsandra Kenchappa and M. Dennis Leo*

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, United States

Front. Cardiovasc. Med., 11 June 2021 | https://doi.org/10.3389/fcvm.2021.687783

46. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2

Yuyang Lei, Jiao Zhang, Cara R Schiavon, Ming He, Lili Chen, Hui Shen, Yichi Zhang, Qian Yin, Yoshitake Cho, Leonardo Andrade, Gerry S Shadel, Mark Hepokoski, Ting Lei, Hongliang Wang, Jin Zhang, Jason X-J Yuan, Atul Malhotra, Uri Manor, Shengpeng Wang, Zu-Yi Yuan, John Y-J Shyy

BioRxiv. 2020;2020.12.04.409144. doi: 10.1101/2020.12.04.409144. Preprint

47. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier

Tetyana P. Buzhdygan, Brandon J. DeOre, Abigail Baldwin-Leclair, Trent A. Bullock, Hannah M. McGary, Jana A. Khan, Roshanak Razmpour, Jonathan F. Hale, Peter A. Galie, Raghava Potula, Allison M. Andrews, and Servio H. Ramireza, Neurobiol Dis. 2020; 146: 105131. Published online 2020 Oct 11. Doi: 10.1016/j.nbd.2020.105131

48. HTLV-1 and HTLV-2 Prevalence in the United States

Lucy B. M. Cook, Graham P. Taylor The Journal of Infectious Diseases, Volume 209, Issue 4, 15 February 2014, Pages 486–487

49. The molecular biology of HIV integrase. Robert Craigie. Future Virol. 2012; 7(7): 679–686.

50. RETROVIRAL INTEGRASE: THEN AND NOW

Mark D. Andrake and Anna Marie Skalka. Annu Rev Virol. 2015; 2(1): 241–264.

51. Prothrombotic immune thrombocytopenia after COVID-19 vaccine.

Tiede A, Sachs UJ, Czwalinna A, Werwitzke S, Bikker R, Krauss JK, Donnerstag FG, Weißenborn K, Höglinger GU, Maasoumy B, Wedemeyer H, Ganser A. Blood. 2021;28:blood.2021011958.

52. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. N Engl J Med. 2021;384(22):2092-2101.

53. Coronavirus (COVID-19) Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT). Aleem A, Nadeem AJ. 2021 Apr 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.

54. Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story. Tsilingiris D, Vallianou NG, Karampela I, Dalamaga M. Metabol Open. 2021;11:100101.

55. Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia. Siegler JE, Klein P, Yaghi S, Vigilante N, Abdalkader M, Coutinho JM, Abdul Khalek F, Nguyen TN. Stroke. 2021;26:STROKEAHA121035613.

56. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination. Sørvoll IH, Horvei KD, Ernstsen SL, Laegreid IJ, Lund S, Grønli RH, Olsen MK, Jacobsen HK, Eriksson A, Halstensen AM, Tjønnfjord E, Ghanima W, Ahlen MT. J Thromb Haemost. 2021;19(7):1813-1818.

57. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure. Wolf ME, Luz B, Niehaus L, Bhogal P, Bäzner H, Henkes H. J Clin Med. 2021;10(8):1599.

58. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Tølbøll Sørensen AL, Rolland M, Hartmann J, Harboe ZB, Roed C, Jensen TØ, Kolte L, El Fassi D, Hillingsø J, Radziwon-Balicka A, Soyka RS, Hansen K, Kirkby N, Goetze JP, Gybel-Brask M, Leinøe EB, Hvas AM, Kampmann P, Stensballe J. Blood Adv. 2021;5(12):2569-2574.

59. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Douxfils J, Favresse J, Dogné JM, Lecompte T, Susen S, Cordonnier C, Lebreton A, Gosselin R, Sié P, Pernod G, Gruel Y, Nguyen P, Vayne C, Mullier F. Thromb Res. 2021;203:163-171.

60. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.

Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, Goldblatt D, Kotoucek P, Thomas W, Lester W. N Engl J Med. 2021;384(23):2202-2211.

61. Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein. Greinacher A, Selleng K, Mayerle J, Palankar R, Wesche J, Reiche S, Aebischer A, Warkentin TE, Muenchhoff M, Hellmuth JC, Keppler O, Duerschmied D, Lother A, Rieg S, Gawaz M, Mueller KAL, Scheer C, Napp M, Hahnenkamp K, Lucchese G, Vogelgesang A, Floeel A, Lovreglio P, Stufano A, Marschalek R, Thiele T. Blood. 2021:blood.2021012938.

62. Perspectives on vaccine induced thrombotic thrombocytopenia.

Dotan A, Shoenfeld Y. J Autoimmun. 2021;121:102663.

63. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination – A report of two UK cases. Mehta PR, Apap Mangion S, Benger M, Stanton BR, Czuprynska J, Arya R, Sztriha LK. Brain Behav Immun. 2021;95:514-517.

64. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors. Von Hundelshausen P, Lorenz R, Siess W, Weber C. Thromb Haemost. 2021. Doi: 10.1055/a-1481-3039.

65. Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience. Bano F, Badugama B, Chandra D. BMJ Case Rep. 2021;14(7):e243894.

66. Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Iba T, Levy JH, Warkentin TE. Crit Care Med. 2021 Jul 13. Doi: 10.1097/CCM.0000000000005211.

67. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). Thaler J, Ay C, Gleixner KV, Hauswirth AW, Cacioppo F, Grafeneder J, Quehenberger P, Pabinger I, Knöbl P. J Thromb Haemost. 2021;19(7):1819-1822.

68. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines.

Long B, Bridwell R, Gottlieb M. Am J Emerg Med. 2021;49:58-61.

69. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia. Favaloro EJ. Int J Lab Hematol. 2021. Doi: 10.1111/ijlh.13629.

70. ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST). Suresh P, Petchey W. BMJ Case Rep. 2021;14(6):e243931. Doi: 10.1136/bcr-2021-243931.

71. Antibody-mediated procoagulant platelets in SARS-CoV-2- vaccination associated immune thrombotic thrombocytopenia. Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller JA, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T. Haematologica. 2021;. doi: 10.3324/haematol.2021.279000.

72. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.

Lai CC, Ko WC, Chen CJ, Chen PY, Huang YC, Lee PI, Hsueh PR. Expert Rev Vaccines. 2021:1-9. Doi: 10.1080/14760584.2021.1949294.

73. Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Ikenberg B, Demleitner AF, Thiele T, Wiestler B, Götze K, Mößmer G, Lingor P. Stroke Vasc Neurol. 2021 Jul 8:svn-2021-001095. Doi: 10.1136/svn-2021-001095.

74. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Warkentin TE. Expert Rev Hematol. 2019;12(8):685-698. Doi: 10.1080/17474086.2019.1636645.

75. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model. Reilly MP, Taylor SM, Franklin C, Sachais BS, Cines DB, Williams KJ, McKenzie SE. J Thromb Haemost. 2006;4(12):2687-94. Doi: 10.1111/j.1538-7836.2006.02201.x.

76. Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia.

Bourguignon A, Arnold DM, Warkentin TE, Smith JW, Pannu T, Shrum JM, Al Maqrashi ZAA, Shroff A, Lessard MC, Blais N, Kelton JG, Nazy I. N Engl J Med. 2021. Doi: 10.1056/NEJMoa2107051.

77. Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study. Göbel CH, Heinze A, Karstedt S, Morscheck M, Tashiro L, Cirkel A, Hamid Q, Halwani R, Temsah MH, Ziemann M, Görg S, Münte T, Göbel H. Pain Ther. 2021; Doi: 10.1007/s40122-021-00296-3.

78. Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism. Rzymski P, Perek B, Flisiak R. Vaccines (Basel). 2021 May;9(6):559.

79. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management. Alam W. Sci Prog. 2021;104(2):368504211025927.

80. Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Marcucci R, Marietta M. Intern Emerg Med. 2021;16(5):1113-1119.

81. Post-SARS-CoV-2-vaccination Cerebral Venous Sinus Thrombosis: an analysis of cases notified to the European Medicines Agency. Krzywicka K, Heldner MR, Sánchez van Kammen M, van Haaps T, Hiltunen S, Silvis SM, Levi M, Kremer Hovinga JA, Jood K, Lindgren E, Tatlisumak T, Putaala J, Aguiar de Sousa D, Middeldorp S, Arnold M, Coutinho JM, Ferro JM. Eur J Neurol. 2021;. doi: 10.1111/ene.15029

82. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.

Sánchez van Kammen M, Heldner MR, Brodard J, Scutelnic A, Silvis S, Schroeder V, Kremer Hovinga JA, Middeldorp S, Levi M, Hiltunen S, Lindgren E, Mansour M, Arauz A, Barboza MA, Zuurbier SM, Aguiar de Sousa D, Ferro JM, Fischer U, Field TS, Jood K, Tatlisumak T, Putaala J, Arnold M, Coutinho JM. JAMA. 2021;326(4):332-338. Doi: 10.1001/jama.2021.9889.

83. Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report. Gonzales M, Pipalia A, Weil A. J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832324. Doi: 10.1177/2324709619832324.

84. Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin.

Arcinas LA, Manji RA, Hrymak C, Dao V, Sheppard JI, Warkentin TE. Transfusion. 2019;59(6):1924-1933. Doi: 10.1111/trf.15263.

85. Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia. Irani M, Siegal E, Jella A, Aster R, Padmanabhan A. Transfusion. 2019;59(3):931-934.

86. Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia. Cines DB, Yarovoi SV, Zaitsev SV, Lebedeva T, Rauova L, Poncz M, Arepally GM, Khandelwal S, Stepanova V, Rux AH, Cuker A, Guo C, Ocariza LM, Travers RJ, Smith SA, Kim H, Morrissey JH, Conway EM. Blood Adv. 2016 Nov 22;1(1):62-74. Doi: 10.1182/bloodadvances.2016000877.

87. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome. Mohanty E, Nazir S, Sheppard JI, Forman DA, Warkentin TE. J Thromb Haemost. 2019;17(5):841-844. Doi: 10.1111/jth.14411.

88. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. Schenk S, El-Banayosy A, Morshuis M, Arusoglu L, Eichler P, Lubenow N, Tenderich G, Koerfer R, Greinacher A, Prohaska W. J Thromb Haemost. 2007;5(2):235-41. Doi: 10.1111/j.1538-7836.2007.02295.x.

89. Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. Cattaneo M. Eur J Intern Med. 2021l;89:22-24. Doi:10.1016/j.ejim.2021.05.031.

90. Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine. A case report. Umbrello M, Brena N, Vercelli R, Foa RA, Femia M, Rossi U, Podda GM, Cortellaro F, Muttini S. J Crit Care. 2021;4;65:72-75. Doi: 10.1016/j.jcrc.2021.05.021.

91. Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.

Costentin G, Ozkul-Wermester O, Triquenot A, Cam-Duchez VL, Massy N, Benhamou Y, Massardier E. J Stroke Cerebrovasc Dis. 2021 Jun 24;30(9):105942. Doi: 10.1016/j.jstrokecerebrovasdis.2021.105942.

92. Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine.

Aladdin Y, Algahtani H, Shirah B. J Stroke Cerebrovasc Dis. 2021 Jun 22;30(9):105938. Doi: 10.1016/j.jstrokecerebrovasdis.2021.105938.

93. Adenovirus-Vectored COVID-19 Vaccine-Induced Immune Thrombosis of Carotid Artery: A Case Report. Walter U, Fuchs M, Grossmann A, Walter M, Thiele T, Storch A, Wittstock M. Neurology. 2021 Jul 26:10.1212/WNL.0000000000012576. doi: 10.1212/WNL.0000000000012576.

94. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Warkentin TE, Makris M, Jay RM, Kelton JG. Am J Med. 2008 Jul;121(7):632-6. Doi: 10.1016/j.amjmed.2008.03.012.

95. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. Ortel TL. Hematology Am Soc Hematol Educ Program. 2009:225-32. Doi: 10.1182/asheducation-2009.1.225.

96. COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis. Pomara C, Sessa F, Ciaccio M, Dieli F, Esposito M, Giammanco GM, Garozzo SF, Giarratano A, Prati D, Rappa F, Salerno M, Tripodo C, Mannucci PM, Zamboni P. Diagnostics (Basel). 2021 May 26;11(6):955. Doi: 10.3390/diagnostics11060955.

97. Heparin-Induced Thrombocytopenia in COVID-19.

Lingamaneni P, Gonakoti S, Moturi K, Vohra I, Zia M. J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620944091. Doi: 10.1177/2324709620944091.

98. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.

Junqueira DR, Zorzela LM, Perini E. Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD007557. Doi: 10.1002/14651858.CD007557.pub3.

99. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.

Thiele T, Ulm L, Holtfreter S, Schönborn L, Kuhn SO, Scheer C, Warkentin TE, Bröker B, Becker K, Aurich K, Selleng K, Hübner NO, Greinacher A. Blood. 2021 May 14:blood.2021012217. doi: 10.1182/blood.2021012217.

100. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine.

Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH, Simonsen CZ, Hvas AM. J Thromb Haemost. 2021 Jul;19(7):1771-1775. Doi: 10.1111/jth.15347.

101. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination – A risk-benefit analysis for people 60 years in Australia. MacIntyre CR, Veness B, Berger D, Hamad N, Bari N. Vaccine. 2021 Jul 10;39(34):4784-7. Doi: 10.1016/j.vaccine.2021.07.013.

102. COVID-19 versus HIT hypercoagulability.

Warkentin TE, Kaatz S. Thromb Res. 2020 Dec;196:38-51. Doi: 10.1016/j.thromres.2020.08.017.

103. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. McFadyen JD, Stevens H, Peter K. Circ Res. 2020 Jul 31;127(4):571-587. Doi: 10.1161/CIRCRESAHA.120.317447.

104. Vaccine-induced immune thrombotic thrombocytopenia (VITT) – a novel clinico-pathological entity with heterogeneous clinical presentations.

Lavin M, Elder PT, O’Keeffe D, Enright H, Ryan E, Kelly A, El Hassadi E, McNicholl FP, Benson G, Le GN, Byrne M, Ryan K, O’Connell NM, O’Donnell JS. Br J Haematol. 2021 Jun 22. Doi: 10.1111/bjh.17613.

105. SARS-CoV-2 and pulmonary embolism: who stole the platelets?

Tran M, Sheth C, Bhandari R, Cameron SJ, Hornacek D. Thromb J. 2020 Sep 3;18:16. Doi: 10.1186/s12959-020-00229-8.

106. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.

Hughes C, Nichols T, Pike M, Subbe C, Elghenzai S. Eur J Case Rep Intern Med. 2020 Apr 29;7(5):001691. Doi: 10.12890/2020_001691.

107. Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Dutta A, Ghosh R, Bhattacharya D, Bhat S, Ray A, Pandit A, Das S, Dubey S. Diabetes Metab Syndr. 2021;15(4):102184. Doi: 10.1016/j.dsx.2021.06.021.

108. Early experience with arterial thromboembolic complications in patients with COVID-19. Indes JE, Koleilat I, Hatch AN, Choinski K, Jones DB, Aldailami H, Billett H, Denesopolis JM, Lipsitz E. J Vasc Surg. 2021;73(2):381-389.e1. doi: 10.1016/j.jvs.2020.07.089.

110.Is the heparin-induced thrombocytopenia-like syndrome associated with ChAdOx vaccine related to the vaccine itself or to an autoimmune reaction to severe acute respiratory syndrome 2 coronavirus: insights and implications from previous reports in infected cases?

AbdelMassih A, Hozaien R, El Shershaby M, Kamel A, Ismail HA, Fouda R. New Microbes New Infect. 2021 May;41:100884. Doi: 10.1016/j.nmni.2021.100884.

111. Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Bersinger S, Lagarde K, Marlu R, Pernod G, Payen JF. Crit Care Med. 2021 Jun 1. Doi: 10.1097/CCM.0000000000005105.

112. A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination.

Guan CY, Tsai SH, Fan JS, Lin YK, Kao CC. Am J Emerg Med. 2021 Jul 8:S0735-6757(21)00571-4. Doi: 10.1016/j.ajem.2021.07.011.

113. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions.

Thakur KT, Tamborska A, Wood GK, McNeill E, Roh D, Akpan IJ, Miller EC, Bautista A, Claassen J, Kim CY, Guekht A, Pardo CA, Williams O, García-Azorín D, Prasad K, Schmutzhard E, Michael BD, Chou SH, Winkler AS, Solomon T, Elkind MS. J Neurol Sci. 2021;427:117532. Doi: 10.1016/j.jns.2021.117532.

114. SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia. Elalamy I, Gerotziafas G, Alamowitch S, Laroche JP, Van Dreden P, Ageno W, Beyer-Westendorf J, Cohen AT, Jimenez D, Brenner B, Middeldorp S, Cacoub P; Scientific Reviewer Committee. Thromb Haemost. 2021 May 4. Doi: 10.1055/a-1499-0119.

115. Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT).

Cliff-Patel N, Moncrieff L, Ziauddin V. Eur J Case Rep Intern Med. 2021 Jun 30;8(7):002692. Doi: 10.12890/2021_002692.

116. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination.

FACME multidisciplinary working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia (Engl Ed). 2021 Jul-Aug;36(6):451-461. Doi: 10.1016/j.nrleng.2021.05.001.

117. Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia.

Park YS. Clin Exp Pediatr. 2021 Jun 30. Doi: 10.3345/cep.2021.00717.

118. Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST).

Esba LCA, Al Jeraisy M. Expert Rev Vaccines. 2021 Jun 17:1-6. Doi: 10.1080/14760584.2021.1940145.

119. Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: What pathogenesis?

De Cristofaro R, Sanguinetti M. Eur J Intern Med. 2021 Jun 29:S0953-6205(21)00231-4. Doi: 10.1016/j.ejim.2021.06.020.

120. An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2. Cerino P, Coppola A, Pierri B, Volzone P, Bruzzese D, Pierri A, Ferro A, Schiavi D, Coppola A, Miniero S, Atripaldi L, Pirozzi C, Rusciano P, Macri A, Boenzi R, Sale S, Brambilla G, Buonerba C. Future Sci OA. 2021 Jun 15;7(8):FSO739. Doi: 10.2144/fsoa-2021-0064.

121. Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination. Gattringer T, Gressenberger P, Gary T, Wölfler A, Kneihsl M, Raggam RB. Stroke Vasc Neurol. 2021 Jul 8:svn-2021-001142. Doi: 10.1136/svn-2021-001142.

122. [Guidelines on: COVID-19 Vaccine Induced Thrombosis, Bleeding, and Thrombocytopenia].

Morais S, Cruz E. Acta Med Port. 2021 Jun 18. Doi: 10.20344/amp.16602.

123. Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?

Gürtler L, Seitz R, Schramm W. Infection. 2021 Jul 21:1-4. Doi: 10.1007/s15010-021-01658-x.

124. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis.

Graf T, Thiele T, Klingebiel R, Greinacher A, Schäbitz WR, Greeve I. J Neurol. 2021 May 22:1-3. Doi: 10.1007/s00415-021-10599-2.

125. Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis.

Marchandot B, Carmona A, Trimaille A, Curtiaud A, Morel O. J Thromb Thrombolysis. 2021 Jun 15:1-3. Doi: 10.1007/s11239-021-02505-4.

126. AZD1222 vaccine-related coagulopathy and thrombocytopenia without thrombosis in a young female. Ryan E, Benjamin D, McDonald I, Barrett A, McHugh J, Ryan K, Enright H. Br J Haematol. 2021 Aug;194(3):553-556. Doi: 10.1111/bjh.17530.

127. Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Furie KL, Cushman M, Elkind MSV, Lyden PD, Saposnik G; American Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2021 Jul;52(7):2478-2482. Doi: 10.1161/STROKEAHA.121.035564.

128. Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination.

McCrae KR. Cleve Clin J Med. 2021 May 6. Doi: 10.3949/ccjm.88a.ccc078.

129. Immune thrombocytopenia: options and new perspectives.

Caserta S, Zaccuri AM, Innao V, Musolino C, Allegra A. Blood Coagul Fibrinolysis. 2021 Jul 1. Doi: 10.1097/MBC.0000000000001058.

130. Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres.

Gras-Champel V, Liabeuf S, Baud M, Albucher JF, Benkebil M, Boulay C, Bron A, El Kaddissi A, Gautier S, Geeraerts T, Girot M, Grandvuillemin A, Laujin H, Jonville-Bera AP, Masmoudi K, Massardier E, Micallef J, Mounier C, Montastruc F, Pariente A, Perez J, Raposo N, Salvo F, Valnet-Rabier MB, Vial T, Massy N; French Network of Pharmacovigilance Centres. Therapie. 2021 May 19:S0040-5957(21)00130-X. Doi: 10.1016/j.therap.2021.05.007.

131. Splanchnic vein thrombosis with thrombopenia in a young, otherwise healthy patient. Fromme M, Zimmermann HW, Bruns T. Gastroenterology. 2021 Jun 16:S0016-5085(21)03136-X. Doi: 10.1053/j.gastro.2021.06.022.

132. SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.

Suvvari TK, Rajesh E, D Silva RG, Corriero AC, Kutikuppala LVS. J Med Virol. 2021 Jul 7. Doi: 10.1002/jmv.27176.

134. Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.

Al-Mayhani T, Saber S, Stubbs MJ, Losseff NA, Perry RJ, Simister RJ, Gull D, Jäger HR, Scully MA, Werring DJ. J Neurol Neurosurg Psychiatry. 2021 May 25:jnnp-2021-326984. Doi: 10.1136/jnnp-2021-326984.

135. COVID-19 vaccine induced prothrombotic immune thrombocytopenia.

Xie C, Vincent L, Chadwick A, Peschl H. Eur Heart J. 2021 May 5:ehab237. Doi: 10.1093/eurheartj/ehab237.

136. Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Garnier M, Curado A, Billoir P, Barbay V, Demeyere M, Dacher JN. Diagn Interv Imaging. 2021:S2211-5684(21)00107-8. Doi: 10.1016/j.diii.2021.04.005.

137. Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Bonato S, Artoni A, Lecchi A, Schwarz G, La Marca S, Padovan L, Clerici M, Guadino C, Comi GP, Tripodi A, Peyvandi F. Haematologica. 2021 Jul 15. Doi: 10.3324/haematol.2021.279246.

138. AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report. Capassoni M, Ketabchi S, Cassisa A, Caramelli R, Molinu AA, Galluccio F, Guiducci S. J Med Virol. 2021 Jul 2. Doi: 10.1002/jmv.27175.

139 . AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.

Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Adams L, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DL. Lancet. 2021 Jul 17;398(10296):207-209. Doi: 10.1016/S0140-6736(21)01462-8. Epub 2021.

140. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.

[No authors listed] N Engl J Med. 2021 Jun 10;384(23):e92. Doi: 10.1056/NEJMx210006.

141. Vaccine-induced immune thrombotic thrombocytopenia: Consider IVIG batch in the treatment. Karnam A, Lacroix-Desmazes S, Kaveri SV, Bayry J. J Thr

338 εμφανίσεις

Σχόλια